Overall objectives

  • Build a leading global group in the market for medical devices
  • Strengthen our offering and our expertise
  • Surpass market growth in selected segments
  • Combine organic growth with acquisitions
  • Continuously increase the proportion of our own products and services.

Financial targets

  • Achieve long term annual growth in excess of 10 percent for the Group.
  • Achieve long term profitability of an operating margin in excess of 13 percent.
  • Achieve share of own product in excess of 13 percent.
  • Net sales including including acquisitions of 1 000 MSEK

Definitions of key performance indicators

TermDescriptionUsage
Total assetsThe value of all assetsRelevant for enabling stakeholders to easily follow changes in consolidated total assets
YieldDividend in relation to share price at balance sheet dateRelevant for providing a measure of the return generated by an equity investment in the form of dividends
Equity per shareEquity attributable to shareholders parent company’s divided by the number of outstanding shares at the end of the periodA measure of the amount of equity that belongs to the shareholders of the parent company
Risk-bearing capitalThe total of the reported amount of equity, any minority interests and deferred tax liabilityRelevant from a credit point of view, and is one component showing the ability to sustain losses
Share of risk-bearing capitalRisk-bearing capital as a percentage of total assetsRelevant from a credit point of view, shows the ability to sustain losses
Liquidity reserveCash and cash equivalents and undrawn bank overdraft facilities at the end of the periodRelevant for assessing the ability to finance future operations as well as variations in the company’s cash flow
Net debtInterest-bearing liabilities and interest-bearing provisions (provisions for pensions) less for cash and cash equivalentsRelevant for assessing the total interest-bearing debt burden
Net sales adjusted for currency translationChanges in net sales adjusted for changes in exchange rates attributable to translation of subsidiaries compared with the same period last yearRelevant for assessing the change in net sales compared with previous year
Operating capitalTotal assets as stated in the balance sheet less non-interest-bearing liabilities, non-interest-bearing provisions, interest-bearing non-current receivables and cash and cash equivalentsCapital tied up in the business
Return on operating capitalOperating profit as a percentage of average operating capitalRelevant for assessing the return on capital tied up in the business
Earnings after tax per shareProfit for the period divided by the average number of sharesRelevant for enabling investors to assess the return on and the valuation of the shares
Operating profit (EBIT)Operating profit before tax and financial itemsRelevant as a measure of the results of the company’s operating activities
Operating margin (EBIT %)Operating profit as a percentage of net salesRelevant for assessing the proportion of revenue retained as profit from operating activities. Can also be used for comparisons between companies
Operating profit before depreciation and amortization (EBITDA)Operating profit before scheduled depreciation and amortization, and impairmentRelevant as a measure of the business’s ability to generate cash flow before tied up working capital and financial activities
EBITDA marginOperating profit before scheduled depreciation and amortization, and impairment, as a percentage of net sales for the yearRelevant as a measure of the business’s ability to generate cash flow in relation to net sales
Debt/equity ratioNet debt divided by equityRelevant for assessing the capital structure, the ratio between equity and debt
Equity ratioEquity including any minority interests as a percentage of total assetsRelevant as a measure of self-financing, as it shows the proportion of assets financed by equity